Market Trends of Disposable Syringes Industry
Retractable Safety Syringes Segment Expected to Witness Significant Growth During the Forecast Period
The retractable safety syringes are used for subcutaneous, intramuscular, and intravenous injections. These syringes possess a safety mechanism that automatically retracts the needle into the plunger after the injection to protect an accidental needle stick and for secondary use.
A retractable safety syringe has a built-in safety mechanism to reduce the risk of needlestick injuries to healthcare workers and others. The needle on a safety syringe can be detachable or permanently attached. In some models, a sheath is placed over the needle; in others, the needle retracts into the barrel. For instance, as per the article published in September 2023 in the Expert Review of Medical Devices, the researchers showed that over 98% of healthcare providers held a notably high regard for the safety of the passive technology in the retractable safety syringes, especially when compared to existing products like a hinge cap active safety needle, a retractable safety needle, and a retractable safety syringe.
The consensus among the HCPs was that the passive safety feature of the needle not only had the potential to eliminate needlestick injury (NSIs) but also offered superior protection against bloodborne pathogens compared to its counterparts. In their collective opinion, this passive safety needle stood out as the safest medical device available. Thus, the advantages of such retractable safety syringes are expected to increase the segment's growth during the forecast period.
For insulin syringes, when the plunger handle is fully depressed, the syringe's needle automatically retracts into its barrel. The syringes include significantly lower dead space volume than a traditional Luer lock syringe and needle, which may result in reduced medication waste. It also provides the clinician a choice of when to activate the safety feature, before or after the needle is withdrawn from the patient. The launch of insulin syringes is one of the major factors driving the segment's growth.
For instance, in November 2023, Terumo India unveiled its Insulin Syringe, tailored for patients needing routine insulin injections, setting a new standard in patient comfort and treatment adherence. Furthermore, in February 2023, Zephyrus Innovations (Zephyrus), a private medical device company specializing in safety syringes and Closed System Transfer Devices (CSTDs), secured its inaugural product 510(k) marketing approval from the United States Food and Drug Administration (FDA) for its Aeroject 3ml safety syringe. The needle system features an internal mechanism that automatically retracts the needle into the syringe upon activation. Activation happens as the forward plunger movement pierces the propellant gas cell in the needle assembly, triggering the needle's retraction.
Hence, the advantages of retractable syringes and innovation in products and launches are expected to increase the demand for these syringes, which may fuel the market's growth in the near future.
North America Expected to Hold Significant Market Share During the Forecast Period
North America is anticipated to hold a significant market share during the forecast period owing to factors such as the high burden of various diseases leading to an increase in the need for diagnosis and treatment, the need for the prevention of infectious diseases, increasing approvals and launches of parenteral drugs. In addition, the government's initiatives to prevent bloodborne infections and the establishment of new hospitals are expected to drive the market’s growth during the forecast period.
The high burden of hospital admissions is expected to contribute to the market's growth. For instance, Canada witnessed a rise in acute inpatient hospitalizations, reaching 2.96 million in 2022–2023, compared to 2.88 million in 2022. The hospitalization rate was 7,000 per 100,000 individuals when normalized for demographic shifts. The high burden of admission in hospitals creates the need for disposable syringes for treatment and diagnosis purposes, which is expected to contribute to the market's growth.
Furthermore, the initiatives taken by the government authority to ensure proper disposal of single-use syringes and avoid multiple usages of disposable syringes are expected to augment the market growth. For instance, in April 2023, the public syringe disposal pilot program was launched in Dover by installing two-needle disposal units. This program addresses public concerns about the improper disposal of syringes in Dover, Delaware. Such initiatives create awareness about the proper use of disposable syringes, hence expected to contribute to the market’s growth.
Moreover, the rising number of new product launches is expected to increase the availability of disposable syringes in the market. For instance, in February 2023, Phillips-Medisize, a Molex company, expanded its product portfolio by introducing a disposable pen injector.
Therefore, owing to the higher risk of acquiring infectious diseases, increasing hospital admissions, growing government initiatives, and rising launches of disposable syringes, the market studied is expected to grow in the North American region during the forecast period.
